What is Aminolevulinic Acid Hydrochloride?
Aminolevulinic acid hydrochloride, also known as 5-ALA hydrochloride, is a small molecule organic acid naturally present in living organisms. It is a scientific research raw material and often appears as white or off white crystalline powder. Aminolevulinic Acid Hydrochloride is a core precursor substance for the synthesis of heme in organisms. After entering cells, it is converted along the biological metabolic pathway to produce protoporphyrin IX. This substance has photosensitive properties and can produce reactive oxygen species under specific wavelength light irradiation, which can then act on target cells. Aminolevulinic Acid Hydrochloride is only used as a research raw material and cannot be directly used as a finished pharmaceutical product. Its direct use without formulation processing can bring various safety hazards and cannot be directly used for human or animal treatment operations.
Molecular Structure Characteristics of Aminolevulinic Acid Hydrochloride
The molecular skeleton of Aminolevulinic Acid Hydrochloride is short and simple, with both amino and carboxyl groups inside the molecule. The form of hydrochloride greatly enhances the solubility of Aminolevulinic Acid Hydrochloride in water. Compared with free aminolevulinic acid, hydrochloride powder is easier to quickly disperse and dissolve in aqueous solution systems, making it convenient for various formula formulations. Aminolevulinic Acid Hydrochloride has a small molecular weight and excellent transmembrane permeability, allowing it to smoothly enter various living cells and initiate subsequent metabolic transformation processes after entering the cells.
The chemical stability of Aminolevulinic Acid Hydrochloride is limited, and it is prone to degradation in aqueous solution. When stored in powder solid state in the dark and dry environment, its activity can be maintained for a longer period of time. Light can accelerate the degradation of Aminolevulinic Acid Hydrochloride molecules, so storing Aminolevulinic Acid Hydrochloride must be sealed away from light and placed in a cool environment to reduce activity loss caused by light exposure. The molecular structure of Aminolevulinic Acid Hydrochloride does not directly damage cells, and it does not possess cell killing ability. All related effects come from the photosensitive products generated by internal metabolism of cells.
As the hydrochloride salt form, Aminolevulinic Acid Hydrochloride exhibits weak acidity in aqueous solutions. When preparing the solution system, attention should be paid to the pH value of the system. Inappropriate acidity or alkalinity can slow down the rate of Aminolevulinic Acid Hydrochloride entering cells and also affect the efficiency of subsequent production of protoporphyrin IX. 5-Aminolevulinatehydrochloride powder has low impurity content after purification, stable physical and chemical indicators between batches, fine powder particles, and is not prone to difficult to dissolve clumps during solution preparation. It is suitable for building testing systems at various cellular levels.
Aminolevulinic Acid Hydrochloride itself is an endogenous metabolic intermediate in organisms. Normal organisms will synthesize a small amount of this substance. After exogenous supplementation of Aminolevulinic Acid Hydrochloride, cells will absorb it as a common metabolic material and will not directly produce strong toxic stimuli. However, excessive intake or prolonged exposure to Aminolevulinic Acid Hydrochloride can lead to the accumulation of protoporphyrin IX in cells. Once exposed to light, it can induce oxidative damage, which is also the core characteristic source of this raw material.
The molecular transformation process of Aminolevulinic Acid Hydrochloride highly relies on the coordinated participation of multiple enzymes within the cell. There is a significant difference in the metabolic conversion efficiency of Aminolevulinic Acid Hydrochloride between healthy cells and abnormally proliferating cells. Cells with faster proliferation rates will absorb more Aminolevulinic Acid Hydrochloride and accumulate more photosensitive substances, which has become the main application basis of this raw material.
Principle of action of Aminolevulinic Acid Hydrochloride
All processes involved in the biosynthesis of hemoglobin require Aminolevulinic Acid Hydrochloride as the starting material. When Aminolevulinic Acid Hydrochloride enters cells, it undergoes multiple enzymatic reactions and gradually transforms into protoporphyrin IX. protoporphyrin IX is a photosensitive substance that is stable in the absence of light and does not have a significant impact on cells. Once exposed to specific wavelengths of visible light, protoporphyrin IX is excited and reacts with surrounding oxygen to generate highly active reactive oxygen species.
Reactive oxygen species have strong oxidative power and can damage the cell membrane, proteins, and nucleic acid structures inside cells, causing cell damage and ultimately rendering the target cells inactive. The entire process is divided into two steps. The first step is the uptake and conversion of Aminolevulinic Acid Hydrochloride by cells to accumulate photosensitive substances. The second step is light triggered oxidative damage. Without light, Aminolevulinic Acid Hydrochloride will not produce such damage effects, which is the most critical characteristic of photodynamic related systems.
The uptake and transformation ability of Aminolevulinic Acid Hydrochloride varies among different cells. Cells with vigorous proliferation have higher metabolic activity, faster absorption of Aminolevulinic Acid Hydrochloride, and significantly higher accumulation of protoporphyrin IX inside the cell compared to normal quiescent cells. This difference allows photodynamic therapy to act more on rapidly proliferating cells, reducing its impact on surrounding normal cells and achieving selective range of action.
Aminolevulinic Acid Hydrochloride does not directly cause DNA breakage, and all cell damage is a secondary result of reactive oxygen species after exposure to light. At the same time, there are metabolic pathways within the cell that can continuously consume protoporphyrin IX and convert it into hemoglobin. Therefore, if the supplementation of Aminolevulinic Acid Hydrochloride is stopped, the accumulated photosensitive substances in the cell will be slowly metabolized and cleared, and the photosensitive effect will gradually weaken and disappear.
The effect of Aminolevulinic Acid Hydrochloride is influenced by various external conditions, such as raw material concentration, incubation time, light wavelength, and light intensity, which can all affect the final effect. When the concentration is too low, the accumulation of protoporphyrin IX in cells is insufficient, and the amount of reactive oxygen species produced after light irradiation is limited, making it difficult to achieve the expected effect; If the concentration is too high, normal cells will also accumulate a large amount of photosensitive substances, expanding non-specific damage.
Main uses of Aminolevulinic Acid Hydrochloride
Aminolevulinic Acid Hydrochloride is commonly used in the construction of photodynamic related systems as a precursor material for testing the effects of photodynamic action on various types of cells, observing changes in cell morphology and activity under different light conditions, and exploring suitable combinations of raw material concentration and light parameters. In the development process of the relevant system, Aminolevulinic Acid Hydrochloride is used to verify the effectiveness of the photodynamic scheme and optimize the entire operation process.
Aminolevulinic Acid Hydrochloride can be used for observing cellular metabolic pathways, studying the entire metabolic chain of heme synthesis, observing the changes in the content of various intermediate products in cells after exogenous addition of Aminolevulinic Acid Hydrochloride, and understanding the regulatory rules of heme synthesis process. With the help of 5-Aminolevulinatehydrochloride, the operational status of cellular metabolic pathways can be visually observed.
Aminolevulinic Acid Hydrochloride is also used in plant physiology related tests. After plants absorb Aminolevulinic Acid Hydrochloride, they can enhance chlorophyll synthesis and regulate plant growth status. In plant cultivation related tests, it is used to observe the changes brought by Aminolevulinic Acid Hydrochloride on seed germination, seedling growth, and stress resistance, and explore plant growth regulation schemes.
Aminolevulinic Acid Hydrochloride can be used as a control material to compare the conversion efficiency of other new photosensitive precursor materials, evaluate the ability of new materials to generate photosensitive products in cells, and horizontally compare the photodynamic activity of different substances, providing a reference benchmark for screening new photosensitive materials.
Aminolevulinic Acid Hydrochloride is only a research raw material and cannot be directly used in humans or animals. Finished photodynamic agents require strict formulation development and safety assessment. Raw material powder is not equivalent to marketed drugs, and direct use of Aminolevulinic Acid Hydrochloride may bring safety risks such as photosensitivity burns. It is necessary to strictly distinguish between raw materials and finished drugs.
The cutting-edge development direction of Aminolevulinic Acid Hydrochloride
The carrier delivery scheme for Aminolevulinic Acid Hydrochloride is continuously being explored. Various carriers are used to encapsulate Aminolevulinic Acid Hydrochloride, enhancing the targeting ability of the raw materials and allowing it to accumulate more in the target cells, reducing its impact on surrounding normal cells and improving the selectivity of the entire photodynamic system. Carrier modification can also improve the stability of Aminolevulinic Acid Hydrochloride in complex environments and delay the degradation of raw materials.
Composite systems with different auxiliary active substances are constantly being developed, combining Aminolevulinic Acid Hydrochloride with other active components to synergistically enhance the effects of photodynamic therapy, reduce the concentration of Aminolevulinic Acid Hydrochloride used, minimize the side effects caused by high concentrations, and search for milder and more efficient combination schemes.
The derivative molecules of Aminolevulinic Acid Hydrochloride are continuously developed by modifying the functional groups based on the original molecular structure, optimizing the cellular uptake ability of the molecules, enhancing molecular stability, prolonging the retention time of photosensitive substances in target cells, and improving the shortcomings of the original Aminolevulinic Acid Hydrochloride, such as short action time and fast metabolism.
In the field of plant applications, we will continue to explore the regulatory effects of low-dose Aminolevulinic Acid Hydrochloride on crop stress resistance and yield increase, search for suitable application concentrations for different crops, explore the potential of Aminolevulinic Acid Hydrochloride in agriculture, and study its role in regulating chlorophyll synthesis and alleviating environmental stress.
Aminolevulinic Acid Hydrochloride is also used as a standard reference material for photosensitive activity detection, establishing a unified evaluation standard to compare the conversion ability of various new photosensitive precursor substances, ensuring comparability of data obtained from different batches and times, and reducing data fluctuations caused by differences in raw material batches.
Conclusion
Aminolevulinic Acid Hydrochloride is a key precursor research raw material for heme synthesis. It has no direct cell damage effect and enters the cell metabolism to generate protoporphyrin IX, which is then exposed to specific light to produce reactive oxygen species. Aminolevulinic Acid Hydrochloride hydrochloride has better water solubility and is commonly used in photodynamic system construction, cell metabolism research, and plant physiology related testing. Aminolevulinic Acid Hydrochloride powder can only be used as a raw material and cannot be directly used as a drug. Currently, optimization of delivery carriers, development of molecular derivatives, and combination of composite systems are the main exploration directions for this raw material.
Xi'an Faithful BioTech Co., Ltd. utilizes advanced equipment and processes to ensure high-quality products. Our 5-Aminolevulinatehydrochloride meets international pharmaceutical standards. Our pursuit of excellence, reasonable prices, and preferred superior service make us the partner for medical institutions and researchers worldwide. If you require Aminolevulinic acid hydrochloride research or production,Please contact us Click email: allen@faithfulbio.com Or WhatsApp: +86 13137770562.
FAQ
Q1: Is Aminolevulinic Acid Hydrochloride cytotoxic on its own?
A: Aminolevulinic Acid Hydrochloride exhibits very low toxicity in the absence of light. It must be converted into protoporphyrin IX within the cell and subsequently activated by light to induce oxidative damage; this effect does not occur in a light-protected environment.
Q2: What is the relationship between Aminolevulinic Acid Hydrochloride and 5-ALA?
A: Aminolevulinic Acid Hydrochloride is the hydrochloride salt form of 5-ALA (aminolevulinic acid). The hydrochloride form offers superior water solubility and is the most commonly used raw material format in the industry.
Q3: Can Aminolevulinic Acid Hydrochloride powder be applied directly?
A: No. Aminolevulinic Acid Hydrochloride is merely a raw material powder; it has not undergone pharmaceutical formulation or safety validation. Direct application poses safety risks, as exposure to light can easily cause photosensitive skin burns.
References
- Kennedy, J. C., Pottier, R. H., & Pross, D. C. (1990). Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. Journal of Photochemistry and Photobiology B: Biology, 6(1-2), 143–158.
- Peng, Q., Berg, K., Moan, J., Kongshaug, M., & Nesland, J. M. (1997). 5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research. Photochemistry and Photobiology, 65(2), 235–251.
- Krammer, B. (2001). Photodynamic therapy with 5-aminolevulinic acid induced protoporphyrin IX. Current Drug Targets, 2(1), 1–17.
- Fritsch, C., & Goerz, G. (2002). 5-Aminolevulinic acid photodynamic therapy: basic principles and practical applications. Journal of Skin Cancer, 2002, 1–10.
- von Tappeiner, H., & Jodlbauer, A. (1904). On the effect of photodynamic (fluorescent) substances on protoplasm. Archiv für Klinische Medizin, 79, 427–470.
- Rittenhouse-Diakun, K., et al. (1995). The role of transferrin receptor in 5-aminolevulinic acid induced protoporphyrin IX accumulation. Photochemistry and Photobiology, 61(1), 73–78.
- Hinnen, P., & Eskens, F. A. (2007). Photodynamic therapy for solid tumors: an update. Cancer Treatment Reviews, 33(4), 305–327.
